Anixa Biosciences (NASDAQ:ANIX) Research Coverage Started at Maxim Group
Maxim Group assumed coverage on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Friday, Marketbeat reports. The firm issued a buy rating and a $10.00 price objective on the stock. A number of other brokerages also recently commented on ANIX. HC Wainwright restated a “buy” rating and issued a […]
Maxim Group assumed coverage on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Friday, Marketbeat reports. The firm issued a buy rating and a $10.00 price objective on the stock. A number of other brokerages also recently commented on ANIX. HC Wainwright restated a “buy” rating and issued a […]
